The 28 references in paper A. Solovyova P., D. Goryachev V., V. Arkhipov V., А. Соловьева П., Д. Горячев В., В. Архипов В. (2018) “Критерии оценки когнитивных нарушений в клинических исследованиях // Criteria for Assessment of Cognitive Impairment in Clinical Trials” / spz:neicon:vedomostincesmp:y:2018:i:4:p:218-230

1
Олефир ЮВ. Результаты проведенного анализа и обобщения материалов по безопасности клинических исследований. Безопасность и риск фармакотерапии. 2017;(1):5–10. [Olefir YuV. The results of the analysis of materials on the safety of clinical trials. Bezopasnost’ i risk farmakoterapii = Safety and Risk of Pharmacotherapy. 2017;(1):5–10 (In Russ.)]
(check this in PDF content)
2
Горячев ДВ, Тельных МЮ, Бунятян НД. Регуляторные подходы к оценке биоаналогов для лечения ревматических заболеваний. Ведомости Научного центра экспертизы средств медицинского применения. 2017;(3):155–63. [Goryachev DV, Telnykh MYu, Bunyatyan ND. Regulatory approaches to evaluation of biosimilars for treatment of rheumatic diseases. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya = Тhе Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2017;(3):155–63 (In Russ.)]
(check this in PDF content)
3
Захаров ВВ. Когнитивные нарушения в неврологической практике. Трудный пациент. 2005;3(5):4–9. [Zakharov VV. Cognitive disorders in neurological practice. Trudny patsient = Difficult Patient. 2005;3(5):4–9 (In Russ.)]
(check this in PDF content)
4
Дамулин ИВ. Сосудистая деменция: некоторые патогенетические, диагностические и терапевтические аспекты. Русский медицинский журнал. 2008;16(5):253–8. [Damulin IV. Vascular dementia: some pathogenetic, diagnostic and therapeutic aspects. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2008;16(5):253–8 (In Russ.)]
(check this in PDF content)
5
Larrabee GJ, Crook TH. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr. 1994;6(1):95–104.
(check this in PDF content)
6
Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological assessment. 5th ed. New York; Oxford University Press: 2012.
(check this in PDF content)
7
Carson N, Leach L, Murphy KJ. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2018;33(2):379–88. https:// doi.org/10.1002/gps.4756
(check this in PDF content)
8
Kessels RPC, Brands AMA. Neuropsychological assessment. In: Biessels GJ, Luchsinger JA, eds. Diabetes and the Brain. Totowa, NJ: Humana Press; 2009. P. 77−102.
(check this in PDF content)
9
Vincent AS, Roebuck-Spencer TM, Fuenzalida E, Gilliland K. Test-retest reliability and practice effects for the ANAM General Neuropsychological Screening battery. Clin Neuropsychol. 2017;32(3):479–94. https:// doi.org/10.1080/13854046.2017.1368716
(check this in PDF content)
10
Webber TA, Soble JR. Utility of various WAIS-IV Digit Span indices for identifying noncredible performance validity among cognitively impaired and unimpaired examinees. Clin Neuropsychol. 2018;32(4):657– 70. https:// doi.org/10.1080/13854046.2017.1415374
(check this in PDF content)
11
Mitrushina MN, Boone KB, Razani J, D’Elia LF. Handbook of normative data for neuropsychological assessment. New York: Oxford University Press; 2005.
(check this in PDF content)
12
Vanderploeg RD, ed. Clinician’s guide to neuropsychological assessment. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 2000.
(check this in PDF content)
13
Folstein MF, Folstein SE, McHugh PR. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.
(check this in PDF content)
14
Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology. 2001;56(9):1133–42.
(check this in PDF content)
15
Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(9):1450–8. https:// doi.org/10.1001/jamainternmed.2015.2152
(check this in PDF content)
16
Lin JS, O’Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, et al. Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force. Report No. 1405198-EF-1. Rockville (MD); 2013.
(check this in PDF content)
17
Stein J, Luppa M, Maier W, Tebarth F, Heser K, Scherer M, et al. The assessment of changes in cognitive functioning in the elderly: age- and education-specific reliable change indices for the SIDAM. Dement Geriatr Cogn Disord. 2012;33(2–3):73–83. https://doi. org/10.1159/000336864
(check this in PDF content)
18
Stein J, Luppa M, Maier W, Wagner M, Wolfsgruber S, Scherer M, et al. Assessing cognitive changes in the elderly: reliable change indices for the Mini-Mental State Examination. Acta Psychiatr Scand. 2012;126(3):208–18. https:// doi.org/10.1111/j.16000447.2012.01850.x
(check this in PDF content)
19
Stein J, Luppa M, Luck T, Maier W, Wagner M, Daerr M, et al. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe). Am J Geriatr Psychiatry. 2012;20(1):84–97. https://doi.org/10.1097/ JGP.0b013e318209dd08
(check this in PDF content)
20
Skinner J, Carvalho JO, Potter GG, Thames A, Zelinski E, Crane PK, et al. The Alzheimer ́s Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI. Brain Imaging Behav. 2012;6(4):489–501. https:// doi.org/10.1007/s11682-012-9166-3
(check this in PDF content)
21
Karin A, Hannesdottir K, Jaeger J, Annas P, Segerdahl M, Karlsson P, et al. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response. Acta Neurol Scand. 2014;129(2):114–22. https://doi. org/10.1111/ane.12153
(check this in PDF content)
22
Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–63. https:// doi.org/10.1016/S0140-6736(15)60461-5
(check this in PDF content)
23
Cedarbaum JM, Jaros M, Hernandez C, Coley N, Andrieu S, Grundman M, et al. Rationale for use of the Clinical Dementia Rating Sum of Boxes as primary outcome measure for Alzheimer’s disease clinical trials. Alzheimers Dement. 2013;9(1 Suppl):45–55. https://doi. org/10.1016/j.jalz.2011.11.002
(check this in PDF content)
24
Wessels AM, Dowsett SA, Sims JR. Detecting treatment group differences in Alzheimer’s disease clinical trials: a comparison of Alzheimer’s disease Assessment Scale — Cognitive Subscale (ADASCog) and the Clinical Dementia Rating — Sum of Boxes (CDR-SB). J Prev Alzheimers Dis. 2018;5(1):15–20. https://doi.org/10.14283/ jpad.2018.2
(check this in PDF content)
25
Langbaum JB, Hendrix SB, Ayutyanont N, Chen K, Fleisher AS, Shah RC, et al. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer’s disease. Alzheimers Dement. 2014;10(6):666–74. https:// doi.org/10.1016/j.jalz.2014.02.002
(check this in PDF content)
26
McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863– 72. https:// doi.org/10.1212/01.wnl.0000187889.17253.b1
(check this in PDF content)
27
Mormile MEE, Langdon JL, Hunt TN. The role of gender in neuropsychological assessment in healthy adolescents. J Sport Rehabil. 2018;27(1):16–21. https:// doi.org/10.1123/jsr.2016-0140
(check this in PDF content)
28
Plourde V, Hrabok M, Sherman EMS, Brooks BL. Validity of a computerized cognitive battery in children and adolescents with neurological diagnoses. Arch Clin Neuropsychol. 2018;33(2):247–53. https://doi. org/10.1093/arclin/acx067 Статья поступила 11.04.2018
(check this in PDF content)